drugset / Trial / NCT02590510
Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis
RandomizedParallel-groupOpen-labelTreatment
Summary
The main purpose of this study is to compare the effect of 10 mg and 15 mg methotrexate in the treatment of meningeal carcinomatosis.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 10 mg | Intrathecal |
| Subject | Methotrexate | Small molecule | 15 mg | Intrathecal |